$3.20
At close: May 7 EDT
$3.45
0.257.81%
Pre-Market: 7:54 PM EDT
Comments
Loading...
Corvus Pharma Stock Guidance | NASDAQ:CRVS | Benzinga
Corvus Pharma issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Corvus Pharmaceuticals Inc (CRVS) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Corvus Pharma (CRVS)?
There have been no specific sales or earnings guidance reported for Corvus Pharma in recent months.
Browse guidance and forecast on all stocks.
